Abstract: This disclosure provides modulators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) having core structure (I), pharmaceutical compositions containing at least one such modulator, methods of treatment of CFTR mediated diseases, including cystic fibrosis, using such modulators and pharmaceutical compositions, combination pharmaceutical compositions and combination therapies employing those modulators, and processes and intermediates for making such modulators.

Abstract: A wireless communication system for batteries removably mountable in local use vehicles and chargeable in a charging repository includes a plurality of batteries, each battery having a housing; a first wireless communication device attached to an outer surface of the housing for receiving and transmitting data; and electrical contacts attached to the housing for selectively providing power to or from the battery. A plurality of second wireless communication devices is mountable to either a one of the local use vehicles or to a location in the charging repository for communication with one of the first wireless communication devices when in an adjacent communication orientation.